跳至主要内容
临床试验/IRCT20230718058835N1
IRCT20230718058835N1尚未招募3 期

Effect of subcutaneous Granulocyte colony stimulating factor (G-CSF) versus placebo on in-vitro fertilization (IVF) results in patients with recurrent implantation failure (RIF): A double-blind, randomized, controlled, clinical trial

Hamedan University of Medical Sciences0 个研究点目标入组 134 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
134

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Age less than 40 years
  • maximum FSH level of 15 IU/ml
  • repeated IVF failure
  • absence of contraindications to receiving G-CSF (active infection, tuberculosis cycle disease, chronic neutropenia, history of malignancy in the past, current malignancy, renal failure, upper respiratory tract infection, congenital fructose intolerance)
  • absence of any systemic diseases (hypertension, diabetes, antiphospholipid syndrome, lupus, thrombophilia and thyroid diseases)

排除标准

  • Insufficient endometrial thickness (minimum 7 mm on the day of HCG injection)
  • hypersensitivity to GCSF
  • diagnosis of Asherman's syndrome
  • diagnosis of polyps and fibroids by hysteroscopy
  • refusal to participate in the study

研究者

相似试验